Joanna Wiensch
Stock Analyst at Citigroup
(2.08)
# 1134
Out of 5,372 analysts
31
Total ratings
73.68%
Success rate
20.71%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BDX Becton Dickinson | Downgrades: Neutral | 217 185 | 170 | 8.82% | 6 | May 22, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 119 127 | 132.22 | -3.95% | 8 | Aug 22, 2024 | |
NVRO Nevro | Downgrades: Neutral | 40 | n/a | n/a | 1 | Jan 17, 2023 | |
DXCM DexCom | Maintains: Buy | 83 91 | 81.82 | 10.3% | 2 | Apr 29, 2020 | |
COO Cooper Companies | Maintains: Neutral | 90 80 | 68.75 | 15.64% | 2 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 144.9 | -17.18% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 200 | 256.19 | -21.93% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 40 | 99.99 | -60% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 168 | 90.18 | 86.29% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 63 | 84.83 | -25.73% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 235 | 373.25 | -37.04% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 220 | 304.17 | -27.67% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 84 | 73.33 | 14.55% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 94 | 29.93 | 214.07% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 163 | 152.38 | 6.97% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 124 | 86.2 | 43.85% | 1 | Mar 5, 2020 |